Last reviewed · How we verify
NCT02539290
Preovulatory Uterine Flushing With Saline as a Treatment for Unexplained Infertility
NA trial testing Detection of ovulation in Unexplained Infertility in 192 participants. Participants enrolled and being followed up; not accepting new ones.
30 September 2024
Quick facts
| Lead sponsor | CHU de Quebec-Universite Laval |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 192 |
| Start date | 30 December 2015 |
| Primary completion | 30 September 2024 |
| Estimated completion | 30 March 2025 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Detection of ovulation
- Uterine flushing
- Vaginal flushing
- Sexual intercourse
Conditions studied
- Unexplained Infertility — all drugs for Unexplained Infertility →
- Infertility — all drugs for Infertility →
Sponsor
CHU de Quebec-Universite Laval — full company profile →
Who can join
Adults 18 to 37, female only, with Unexplained Infertility or Infertility. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine whether preovulatory uterine flushing with physiological saline is effective in the treatment of unexplained infertility.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Preovulatory uterine flushing with saline as a treatment for unexplained infertility: a randomised controlled trial protocol.
Maheux-Lacroix S, Dodin S, Moore L, Bujold E, et al · · 2016 · cited 9× · PMID 26739737 · DOI 10.1136/bmjopen-2015-009897
Verify or expand the search:
- PubMed search for NCT02539290
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Unexplained Infertility
Currently open trials in the same condition.
- NCT06481696 — Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility · NA · recruiting
- NCT06491251 — Varicocelectomy in Patients With Clinical Varicocele and Unexplained Infertility · NA · recruiting
Other CHU de Quebec-Universite Laval trials
Trials by the same sponsor.
- NCT07067827 — Self-questionnaire in Osteoporosis · recruiting
- NCT06018116 — A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer. · Phase 2 · withdrawn
- NCT05941806 — Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection · Phase 3 · unknown
- NCT06351176 — Impact of Glycemic Control on Skeletal Outcomes in Adults With Type 1 Diabetes · enrolling by invitation
- NCT05859139 — Scaling a Decision Aid on Prenatal Screening for Trisomy 21, 18 and 13 · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02539290 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CHU de Quebec-Universite Laval
- Last refreshed: 13 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02539290.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing